In vivo correction of a Menkes disease model using antisense oligonucleotides.

In vivo correction of a Menkes disease model using antisense oligonucleotides. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

In vivo correction of a Menkes disease model using antisense oligonucleotides. Abstract Text:

Erik C Madsen,Paul A Morcos,Bryce A Mendelsohn,Jonathan D Gitlin,

Although the molecular basis of many inherited metabolic diseases has been defined, the availability of effective therapies in such disorders remains problematic. Menkes disease is a fatal neurodegenerative disorder due to loss-of-function mutations in the ATP7A gene encoding a copper-transporting P-type Atpase. To develop therapeutic approaches in affected patients, we have identified a zebrafish model of Menkes disease termed calamity that results from splicing defects in the zebrafish orthologue of the ATP7A gene. Embryonic-recessive lethal mutants have impaired copper homeostasis that results in absent melanin pigmentation, impaired notochord formation, and hindbrain neurodegeneration. In this current study, we have attempted to rescue these striking phenotypic alterations by using a series of antisense morpholino oligonucleotides directed against the splice-site junctions of two mutant calamity alleles. Our findings reveal a robust and complete correction of the copper-deficient defects of calamity in association with the generation of the WT Menkes protein in all rescued mutants. Interestingly, a quantitative analysis of atp7a-specific transcripts suggests that competitive translational regulation may account for the synthesis of WT protein in these embryos. This in vivo correction of Menkes disease through the rescue of aberrant splicing may provide therapeutic options in this fatal disease and illustrates the potential for zebrafish models of human genetic disease in the development of treatments based on the principles of interactions of synthetic oligonucleotide analogues with mRNA.

In vivo correction of a Menkes disease model using antisense oligonucleotides. Publishing Authors By Initials

EC Madsen,PA Morcos,BA Mendelsohn,JD Gitlin,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

In vivo correction of a Menkes disease model using antisense oligonucleotides. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Proceedings of the National Academy of Sciences of

VOLUME: 105

Page Numbers: 3909-14

Journal Abbreviation:

ISSN: 1091-6490

DAY: 3

MONTH: 03

YEAR: 2008

In vivo correction of a Menkes disease model using antisense oligonucleotides. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7505876

In vivo correction of a Menkes disease model using antisense oligonucleotides. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: In vivo correction of a Menkes disease model using antisense oligonucleotides. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for In vivo correction of a Menkes disease model using antisense oligonucleotides.

AFFILIATION: Edward Mallinckrodt Department of Pediatrics, Washington University School of Medicine, St. Louis, MO 63110, USA.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Proc Natl Acad Sci U S A

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

In vivo correction of a Menkes disease model using antisense oligonucleotides Related Publications

• ATAXIA TELANGIECTASIS. A DYSGAMMAGLOBULINAEMIA WITH DEFICIENT GAMMA-1-A (BETA-2-A)-GLOBULIN.
• Assembling the pieces.
• Atomic energy or the atomic bomb; a problem in the development or morale and opinion.
• Augmentation strategies in the treatment of major depressive disorder. Clinical considerations with atypical antipsychotic augmentation.
• Coordination of development and metabolism in the pre-midblastula transition zebrafish embryo.
• Copper and iron disorders of the brain.
• Copper deficiency.
• Dysgammaglobulinaemia and recurrent bacterial infection.
• Essential role for fibrillin-2 in zebrafish notochord and vascular morphogenesis.
• Essential role of lysyl oxidases in notochord development.
• Further characterization of IgG receptors from human placenta.
• In vivo correction of a Menkes disease model using antisense oligonucleotides.
• Intracellular localization of the Menkes and Wilson's disease proteins and their role in intracellular copper transport.
• The zebrafish embryo as a dynamic model of anoxia tolerance.
• Use of ultraviolet absorption spectroscopy in the quantitative precipitin reaction.
• Zieve's syndrome and porphyrinuria in an alcoholic.